Navigation Links
The birth of biotech: San Francisco, Boston, Geneva or Chicago?

CHICAGO To start off our day, heres a pop biotech quiz to see if you know your biotech history and trivia:
  1. What were the first six biotech companies?
  2. How many of these companies still exist?
  3. How many of them are still completely independent?

While Im willing to bet that most of you will get at least three of the six companies right in the first question, ......

Full article >>> "http://www.wyeth.com">Wyeth.

Cetus, originally located in San Francisco and founded in the late 1970s as an innovative cancer therapy company, was acquired by Chiron in the early 1990s.

Amgen, which was originally known as Applied Molecular Genetics, was founded......

Full article >>> st monoclonal antibodies are produced.
  • 1977: The first expression of a human gene in bacteria.
  • 1978: Recombinant insulin is first produced.
  • 1979: Human growth hormone is first synthesized.
  • Also in the 1970s: RNA splicing, gene targeting, discovery of polymerases and of course the first commercial companies to develop genetically engineered products.
    During ......

    Full article >>> sity of Chicago.

    Goldwasser was born in 1922 (hes 82 today) in Brooklyn. After his family moved to Kansas City, he won a scholarship to University of Chicago and majored in biological sciences. During his initial time there, Goldwasser worked in the universitys toxicity lab on antidotes for chemical warfare agents (this was after the Japanese attack on Pearl Harbor).

    Upon graduat......

    Full article >>> o three dialysis patients with his small supply of EPO.

    His goal was to demonstrate an effect on patients with anemia of chronic renal disease. He also advised the University of Chicago and the government that he had a patentable invention. When he didnt hear back from these groups, he forgot about patenting his discovery.

    The results of his small Phase I were promising but incon......

    Full article >>> years later for $250 million). This helped the new company attract west coast VCs, which put up another $12 million. With this investment, the new company was off and running.

    Once funded, EPO became one of the lead projects and Salser invited Goldwasser to join the new Amgens scientific advisory board. Goldwasser preferred to work for Amgen as a consultant and Goldwasser provided Amgen ......

    Full article >>> wasser continued to investigate other aspects of EPO and focused on the kidney cells that produce EPO. While Amgen continued to support his lab at the rate of about $30,000 per year, the NIH lost interest in his work.

    As Goldwasser never patented any of his work, his financial share of Amgens successful sales of EPO never materialized.

    Still, he clearly was the pivotal person in ......

    Full article >>>
    '"/>


  • Source:wistechnology.com By Michael Rosen 08/25/04


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Health-care eyes focus on San Francisco, war of the stents
    3. Historic observatory becomes hot property on Lake Geneva
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
    (Date:3/23/2017)... NEW YORK , March 23, 2017 ... ... causes of death, putting significant strain on health care systems, ... of cancer diagnoses rises, so too does the development of ... with minimum side effects. Among the many types of cancer ...
    (Date:3/23/2017)... ... 23, 2017 , ... Advanced Polymer Monitoring Technologies (APMT), a ... “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd will lead ... Floyd’s career has spanned 30 years in the chemicals and equipment industries. Sig ...
    (Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
    Breaking Biology Technology:
    (Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
    (Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
    (Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
    Breaking Biology News(10 mins):